The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant

5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Choon Kit, Aoshi, Taiki, Jounai, Nao, Ito, Junichi, Ohata, Keiichi, Kobiyama, Kouji, Dessailly, Benoit H., Kuroda, Etsushi, Akira, Shizuo, Mizuguchi, Kenji, Coban, Cevayir, Ishii, Ken J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605442/
https://www.ncbi.nlm.nih.gov/pubmed/23555875
http://dx.doi.org/10.1371/journal.pone.0060038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605442/
https://www.ncbi.nlm.nih.gov/pubmed/23555875
http://dx.doi.org/10.1371/journal.pone.0060038

Ejemplares similares